Showing results (91-100 of 113) with videos related to
Sort By:
Pageof 12
BMJ (Clinical Research Ed.)|February 5, 2011
Effect of training traditional birth attendants on neonatal mortality (Lufwanyama Neonatal Survival Project): randomised controlled studyChristopher J Gill, Grace Phiri-Mazala, Nicholas G Guerina, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 1, 2022
Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081Conrado Milani Coutinho, Meredith G Warshaw, Geraldo Duarte, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 23, 2022
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026sKristina M Brooks, Mauricio Pinilla, Alice M Stek, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2011
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapineRussell B Van Dyke, Nicole Ngo-Giang-Huong, David E Shapiro, et al.Clinical Pharmacokinetics|November 12, 2025
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and PostpartumYifan Yu, Kristina M Brooks, Gustavo F Doncel, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2025
Pharmacokinetics and Safety of Bictegravir in Pregnant and Postpartum Persons With HIV and Their InfantsKathleen M Powis, Mauricio Pinilla, Flynn McMorrow, et al.The Journal of Infectious Diseases|October 30, 2025
Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026sJennifer A Hughes, Flynn McMorrow, Kristina M Brooks, et al.AIDS (London, England)|June 2, 2021
Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIVJeremiah D Momper, Jiajia Wang, Alice Stek, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2013
Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of lifeMark Mirochnick, Taha Taha, Regis Kreitchmann, et al.The Lancet. HIV|November 26, 2020
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept studyTheodore D Ruel, Edmund V Capparelli, Camlin Tierney, et al.Pageof 12